Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Buldini

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
Pediatric Blood & Cancer|December 9, 2008
Advanced pediatric myelodysplastic syndromes: can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool?Marinella Veltroni, Laura Sainati, Marco Zecca, et al.
Cytometry. Part B, Clinical Cytometry|June 24, 2015
Expression of the immunoglobulin superfamily cell membrane adhesion molecule Cd146 in acute leukemiaFrancesco Cavazzini, Diana Campioni, Luisa Ferrari, et al.
British Journal of Haematology|January 24, 2018
Pre- and post-transplant minimal residual disease predicts relapse occurrence in children with acute lymphoblastic leukaemiaFederica Lovisa, Marco Zecca, Bartolomeo Rossi, et al.
Pediatric Blood & Cancer|December 19, 2018
Flow-cytometric minimal residual disease monitoring in blood predicts relapse risk in pediatric B-cell precursor acute lymphoblastic leukemia in trial AIEOP-BFM-ALL 2000Angela Schumich, Margarita Maurer-Granofszky, Andishe Attarbaschi, et al.
Haematologica|May 24, 2015
Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemiaLeonid Karawajew, Michael Dworzak, Richard Ratei, et al.
Oncotarget|July 16, 2014
Low PKCα expression within the MRD-HR stratum defines a new subgroup of childhood T-ALL with very poor outcomeGloria Milani, Paola Rebora, Benedetta Accordi, et al.
American Journal of Hematology|September 4, 2025
Sensitivity of Pediatric Myelodysplastic Syndromes With Excess of Blasts With UBTF-TD to Venetoclax/AzacitidinePietro Merli, Riccardo Masetti, Martina Pigazzi, et al.
Tumori|April 20, 2021
Childhood cancer in Italy: background, goals, and achievements of the Italian Paediatric Hematology Oncology Association (AIEOP)Marco Zecca, Andrea Ferrari, Paola Quarello, et al.
Leukemia|February 24, 2018
Epigenetic heterogeneity affects the risk of relapse in children with t(8;21)RUNX1-RUNX1T1-rearranged AMLMatteo Zampini, Claudia Tregnago, Valeria Bisio, et al.
Cancers|May 28, 2022
FLT3-ITD in Children with Early T-cell Precursor (ETP) Acute Lymphoblastic Leukemia: Incidence and Potential Target for Monitoring Minimal Residual Disease (MRD)Luca Lo Nigro, Nellina Andriano, Barbara Buldini, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Pediatric Blood & Cancer|December 9, 2008
Advanced pediatric myelodysplastic syndromes: can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool?Marinella Veltroni, Laura Sainati, Marco Zecca, et al.
Cytometry. Part B, Clinical Cytometry|June 24, 2015
Expression of the immunoglobulin superfamily cell membrane adhesion molecule Cd146 in acute leukemiaFrancesco Cavazzini, Diana Campioni, Luisa Ferrari, et al.
British Journal of Haematology|January 24, 2018
Pre- and post-transplant minimal residual disease predicts relapse occurrence in children with acute lymphoblastic leukaemiaFederica Lovisa, Marco Zecca, Bartolomeo Rossi, et al.
Pediatric Blood & Cancer|December 19, 2018
Flow-cytometric minimal residual disease monitoring in blood predicts relapse risk in pediatric B-cell precursor acute lymphoblastic leukemia in trial AIEOP-BFM-ALL 2000Angela Schumich, Margarita Maurer-Granofszky, Andishe Attarbaschi, et al.
Haematologica|May 24, 2015
Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemiaLeonid Karawajew, Michael Dworzak, Richard Ratei, et al.
Oncotarget|July 16, 2014
Low PKCα expression within the MRD-HR stratum defines a new subgroup of childhood T-ALL with very poor outcomeGloria Milani, Paola Rebora, Benedetta Accordi, et al.
American Journal of Hematology|September 4, 2025
Sensitivity of Pediatric Myelodysplastic Syndromes With Excess of Blasts With UBTF-TD to Venetoclax/AzacitidinePietro Merli, Riccardo Masetti, Martina Pigazzi, et al.
Tumori|April 20, 2021
Childhood cancer in Italy: background, goals, and achievements of the Italian Paediatric Hematology Oncology Association (AIEOP)Marco Zecca, Andrea Ferrari, Paola Quarello, et al.
Leukemia|February 24, 2018
Epigenetic heterogeneity affects the risk of relapse in children with t(8;21)RUNX1-RUNX1T1-rearranged AMLMatteo Zampini, Claudia Tregnago, Valeria Bisio, et al.
Cancers|May 28, 2022
FLT3-ITD in Children with Early T-cell Precursor (ETP) Acute Lymphoblastic Leukemia: Incidence and Potential Target for Monitoring Minimal Residual Disease (MRD)Luca Lo Nigro, Nellina Andriano, Barbara Buldini, et al.
Pageof 9